Wednesday, July 8, 2026

Drug profile · INN

sinecatechins

sinecatechins (VEREGEN) is a unknown. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — sinecatechins
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
2
Data quality
0.84

Quick answer

sinecatechins (VEREGEN) is a unknown. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN sinecatechins
Brand VEREGEN
Mechanism Unknown
Route TOPICAL
Formulation OINTMENT

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. SINECATECHINS Approved · George Institute for · Anal high-grade squamous intraepithelial lesions (HSIL).
  2. Regen Matrix-PRP-XLHA Unknown · Regeneron Ireland Designated · Knee Osteoarthritis

Frequently asked questions

What is sinecatechins?

sinecatechins (VEREGEN) is a unknown. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for sinecatechins?

VEREGEN is a marketed brand name for sinecatechins. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sinecatechins?

sinecatechins has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.